charlotte tan

Pediatric cancer patient checks in at age 55; beneficiary of Dr Charlotte Tan's actinomycin D work

terrasig | June 30, 2009

I love it when new readers stumble upon old posts. Such was the case when I received the following delightful comment from Seattle-based psychologist, Dr Gary Grenell, on my April 2008 post about the passing of Dr Charlotte Tan, a pediatric cancer chemotherapy pioneer: I was probably in one of her earliest actionmycin-D trial groups for Wilms tumor in 1957. Now at age 55, 52 years later, still going strong! Most of you scientific youngsters today probably only know of actinomycin D as a laboratory tool for inhibiting RNA synthesis. But here in the following repost, learn about the…

Advertisment

Donate

ScienceBlogs is where scientists communicate directly with the public. We are part of Science 2.0, a science education nonprofit operating under Section 501(c)(3) of the Internal Revenue Code. Please make a tax-deductible donation if you value independent science communication, collaboration, participation, and open access.

You can also shop using Amazon Smile and though you pay nothing more we get a tiny something.

Science 2.0

Science Codex

Pediatric cancer patient checks in at age 55; beneficiary of Dr Charlotte Tan's actinomycin D work

Rebuilding

040/366: SoccerKid

Meet the new white cell, same as the old white cell